alexa Leandro Bueno Bergantin | OMICS International | Federal
ISSN: 2167-1052

Advances in Pharmacoepidemiology and Drug Safety
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Leandro Bueno Bergantin
Leandro Bueno Bergantin Leandro Bueno Bergantin
Researcher (FAPESP)
Federal University of São Paulo - UNIFESP / EPM
Functional Laboratory - Research Building II
Paulista Medical School,
Brazil
Biography

Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil) and UAM (Spain): degree in biomedicine (2008), MSc (2010) and PhD (2014). His research involves cell signaling mediated by Ca2+ and cAMP, skeletal and smooth muscles, peripheral and central nervous systems. His research work solved the enigma of the paradoxical effects produced by Ltype Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014). Since 1975, several clinical and experimental studies have reported that acute and chronic administration of L-type Ca2+ channel blockers (CCB), such as nifedipine, produces reduction in arterial pressure associated with a paradoxical increase of sympathetic activity. Despite this sympathetic hyperactivity has been initially attributed to adjust reflex of arterial pressure, the cellular and molecular mechanisms involved in this apparent sympathomimetic effect of the L-type CCB remained unclear for decades. In 2013, Dr. Bergantin and collaborators discovered that this paradoxical increase in sympathetic activity produced by L-type CCB is due to interaction of the Ca2+/cAMP signaling pathways. Then, the pharmacological manipulation of the Ca2+/cAMP interaction produced by combination of the L-type CCB used in the antihypertensive therapy, and cAMP accumulating compounds used in the antidepressive therapy, could represent a potential cardiovascular risk for hypertensive patients due to increase in sympathetic activity. In contrast, this pharmacological manipulation could be a new therapeutic strategy for increasing neurotransmission in psychiatric disorders, and producing neuroprotection in the neurodegenerative diseases (Bergantin and Caricati-Neto, 2016 Eur J Pharmacol; Caricati-Neto et al., 2015 Pharm Res Perspect). Dr. Bergantin has published several articles in international journals, book chapters, and an international book. He is member of 20 editorial boards of international journals. Dr. Bergantin has been frequently invited to be honorable guest (speaker) in international conferences (e.g.: more than 30 invitations in 2016).

 

 

Research Interest

Pharmacology, Biochemistry, Genetics, Molecular Biology, Antihypertensive therapy, Biomedicine, Neurodegenerative diseases

Publications

The Second Messengers Ca2+ and camp as Potential Therapeutic Targets for the Control of Cancer Progression
Paolo Ruggero Errante, Francisco Sandro Menezes-Rodrigues, Alberto Andrade Leite, Afonso Caricati-Neto and Leandro Bueno Bergantin*
Editorial: Adv Cancer Prev 2: e105
DOI: 10.4172/2472-0429.1000e105
 
Extracellular Cyclic AMP/Adenosine Signaling Pathway: A Potential Pharmacological Target for Therapeutic Intervention in Chronic Lymphocytic Leukemia
Francisco Sandro Menezes-Rodrigues, Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e104
DOI: 10.4172/2472-0429.1000e104
 
A Simple and Efficient Methodology for the Study of Cardioprotective Drugs in Animal Model of Cardiac Ischemia-Reperfusion
Jose Gustavo Padrao Tavares, Francisco Sandro Menezes-Rodrigues, Enio Rodrigues Vasques, Maria do Carmo Maia Reis, Luciana de Paula, Bráulio Luna-Filho, Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin*
Research Article: J Mol Imaging Dynam
DOI: 10.4172/2155-9937.1000133
 
Sudden Unexpected Death in Parkinson’s Disease and the Pharmacological Modulation of the Ca2+/cAMP Signaling Interaction: A Shot of Good News
Afonso Caricati-Neto1, Fúlvio Alexandre Scorza2 ,Carla Alessandra Scorza2, Roberta Monterazzo Cysneiros3, Francisco Sandro Menezes- Rodrigues1, and Leandro Bueno Bergantin1*
Short Communication: Brain Disord Ther 2017, 6:231
DOI: 10.4172/2168-975X.1000231
 
Insights for the Inhibition of Cancer Progression: Revisiting Ca2+ and Camp Signalling Pathways
Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e103
DOI: 10.4172/2472-0429.1000e103
 
A 4-Decade Enigma, Two Researchers and a Wonderful History
Leandro Bueno Bergantin and Afonso Caricati-Neto
Editorial: Fam Med Med Sci Res 2017, 6:e109
DOI: 10.4172/2327-4972.1000e109
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version